STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong

Дата публикации: 02-07-2026 08:30:00

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala Fakhouri says.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Ford Brings Back Veteran Engineers After AI Falls Short: 'It's Only As Good As The People Using It' (Update)	0	8	01-07-2026
2	Фалькова попросили проинформировать о контроле за использованием ИИ в науке	0	0	07-04-2025
3	STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings	0	5	02-07-2026
4	STAT+: Halfway into the year, biotech is booming	5	7	02-07-2026
5	The Private Firms Powering China’s Military AI Push	0	5	24-03-2026
6	STAT+: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?	0	5	02-07-2026
7	Bill Proposes Federal Agency to Focus on AI	0	7	26-06-2026
8	AI boom faces growing community backlash	0	5	05-06-2026
9	The government wants to rein in powerful AI, but there are downsides	0	5	27-06-2026
10	US Stock market: Fed's Daly says AI, inflation uncertainty clouds interest rate outlook	0	7	03-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.statnews.com.